Literature DB >> 23061389

Comparison of pulsed versus continuous convective flow for central nervous system tissue perfusion: laboratory investigation.

Edjah K Nduom1, Stuart Walbridge, Russell R Lonser.   

Abstract

OBJECT: Although pulsatile and continuous infusion paradigms have been described for convective delivery of drugs, the effectiveness and properties of each flow paradigm are unknown. To determine the effectiveness and properties of pulsatile and continuous convective infusion paradigms, the authors compared these convective flow methods in the gray and white matter of primates.
METHODS: Six primates (Macaca mulatta) underwent convective infusion of Gd-DPTA (5 mM) into the cerebral gray matter (thalamus) or white matter (frontal lobe) using pulsed (intermittent pulses of 15 μl/min) or continuous (1 μl/min) convective flow. Results were assessed by clinical MRI and histological analyses.
RESULTS: Distribution of Gd-DTPA infusate in gray and white matter by pulsed and continuous flow was clearly identified using MRI, which revealed that both convective flow methods demonstrated an increase in the volume of distribution (Vd) with increasing volume of infusion (Vi) in the surrounding gray and white matter. Although the mean (± SD) gray matter Vd:Vi ratio for the pulsed infusions (4.2 ± 0.5) was significantly lower than the mean Vd:Vi ratio for continuous infusions (5.4 ± 0.5; a 22% difference [p = 0.0006]), the difference between pulsed (3.8 ± 0.4) and continuous (4.3 ± 1.2) infusions in white matter was not significantly different (p = 0.3). Pulsed infusions were associated with more leakback (12.3% ± 6.4% of Vi) than continuous infusions (3.9% ± 7.8%), although this difference was not significant (p = 0.2). All animals tolerated the infusions and there was no histological evidence of tissue injury at the infusion sites.
CONCLUSIONS: Although pulsed and continuous infusion flow paradigms can be safely and effectively used for convective delivery into both gray and white matter, continuous infusion is associated with a higher Vd:Vi ratio than pulsatile infusion in gray matter. High rates of infusion (15 μl/min) can be used to deliver infusate without any significant leakback and without any clinical or histological evidence of injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061389      PMCID: PMC4746716          DOI: 10.3171/2012.9.JNS12506

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  19 in total

1.  Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging.

Authors:  Tung T Nguyen; Yashdip S Pannu; Cynthia Sung; Robert L Dedrick; Stuart Walbridge; Martin W Brechbiel; Kayhan Garmestani; Markus Beitzel; Alexander T Yordanov; Edward H Oldfield
Journal:  J Neurosurg       Date:  2003-03       Impact factor: 5.115

2.  Assessment of a balloon-tipped catheter modified for intracerebral convection-enhanced delivery.

Authors:  Jeffrey J Olson; Zhaobin Zhang; Dirk Dillehay; James Stubbs
Journal:  J Neurooncol       Date:  2008-05-06       Impact factor: 4.130

3.  Trophic factor distribution predicts functional recovery in parkinsonian monkeys.

Authors:  Don M Gash; Zhiming Zhang; Yi Ai; Richard Grondin; Robert Coffey; Greg A Gerhardt
Journal:  Ann Neurol       Date:  2005-08       Impact factor: 10.422

4.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

5.  Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal.

Authors:  John T Slevin; Don M Gash; Charles D Smith; Greg A Gerhardt; Richard Kryscio; Himachandra Chebrolu; Ashley Walton; Renee Wagner; A Byron Young
Journal:  J Neurosurg       Date:  2007-04       Impact factor: 5.115

6.  Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study.

Authors:  Alexandre Carpentier; Philippe Metellus; Renata Ursu; Sarah Zohar; Francois Lafitte; Maryline Barrié; Yuxia Meng; Margaretha Richard; Christophe Parizot; Florence Laigle-Donadey; Guy Gorochov; Dimitri Psimaras; Marc Sanson; Annick Tibi; Olivier Chinot; Antoine F Carpentier
Journal:  Neuro Oncol       Date:  2010-01-25       Impact factor: 12.300

7.  Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors.

Authors:  D W Laske; R J Youle; E H Oldfield
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

8.  Real-time imaging of convection-enhanced delivery of viruses and virus-sized particles.

Authors:  Nicholas J Szerlip; Stuart Walbridge; Linda Yang; Paul F Morrison; Jeffrey W Degen; S Taylor Jarrell; Joshua Kouri; P Benjamin Kerr; Robert Kotin; Edward H Oldfield; Russell R Lonser
Journal:  J Neurosurg       Date:  2007-09       Impact factor: 5.115

9.  Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.

Authors:  John H Sampson; Gamal Akabani; Gerald E Archer; Mitchel S Berger; R Edward Coleman; Allan H Friedman; Henry S Friedman; Kim Greer; James E Herndon; Sandeep Kunwar; Roger E McLendon; Alison Paolino; Neil A Petry; James M Provenzale; David A Reardon; Terence Z Wong; Michael R Zalutsky; Ira Pastan; Darell D Bigner
Journal:  Neuro Oncol       Date:  2008-04-10       Impact factor: 12.300

10.  Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note.

Authors:  Russell R Lonser; Katherine E Warren; John A Butman; Zenaide Quezado; R Aaron Robison; Stuart Walbridge; Raphael Schiffman; Marsha Merrill; Marion L Walker; Deric M Park; David Croteau; Roscoe O Brady; Edward H Oldfield
Journal:  J Neurosurg       Date:  2007-07       Impact factor: 5.115

View more
  3 in total

1.  Magnetic resonance imaging properties of convective delivery in diffuse intrinsic pontine gliomas.

Authors:  Prashant Chittiboina; John D Heiss; Katherine E Warren; Russell R Lonser
Journal:  J Neurosurg Pediatr       Date:  2014-01-10       Impact factor: 2.375

2.  Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors.

Authors:  Rolf F Barth; Gong Wu; W Hans Meisen; Robin J Nakkula; Weilian Yang; Tianyao Huo; David A Kellough; Pravin Kaumaya; Claudia Turro; Lawrence M Agius; Balveen Kaur
Journal:  Onco Targets Ther       Date:  2016-05-10       Impact factor: 4.147

3.  MRI-guided intracerebral convection-enhanced injection of gliotoxins to induce focal demyelination in swine.

Authors:  Lukasz Kalkowski; Izabela Malysz-Cymborska; Dominika Golubczyk; Miroslaw Janowski; Piotr Holak; Kamila Milewska; Dorota Kedziorek; Zbigniew Adamiak; Wojciech Maksymowicz; Piotr Walczak
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.